Use of Azacitidine and Venetoclax Combination in the Treatment of Relapsed Acute Myeloid Leukemia: Experience of Two Clinical Cases
Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), 2025, onmt_A21
Publication date: Oct 06, 2025
ABSTRACT
---
KEYWORDS
---
CITATION (Vancouver)
Suleimenova A, Kemaykin V, Adusheva B, Dossaeva S, Mussakhanova A, Yeskendirova S. Use of Azacitidine and Venetoclax Combination in the Treatment of Relapsed Acute Myeloid Leukemia: Experience of Two Clinical Cases. Oncology, Nuclear Medicine and Transplantology. 2025;1(Suppl. 1):onmt_A21.
APA
Suleimenova, A., Kemaykin, V., Adusheva, B., Dossaeva, S., Mussakhanova, A., & Yeskendirova, S. (2025). Use of Azacitidine and Venetoclax Combination in the Treatment of Relapsed Acute Myeloid Leukemia: Experience of Two Clinical Cases. Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), onmt_A21.
Harvard
Suleimenova, A., Kemaykin, V., Adusheva, B., Dossaeva, S., Mussakhanova, A., and Yeskendirova, S. (2025). Use of Azacitidine and Venetoclax Combination in the Treatment of Relapsed Acute Myeloid Leukemia: Experience of Two Clinical Cases. Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), onmt_A21.
AMA
Suleimenova A, Kemaykin V, Adusheva B, Dossaeva S, Mussakhanova A, Yeskendirova S. Use of Azacitidine and Venetoclax Combination in the Treatment of Relapsed Acute Myeloid Leukemia: Experience of Two Clinical Cases. Oncology, Nuclear Medicine and Transplantology. 2025;1(Suppl. 1), onmt_A21.
Chicago
Suleimenova, A.S., V.M. Kemaykin, B.A. Adusheva, S.D. Dossaeva, A.A. Mussakhanova, and S.M. Yeskendirova. "Use of Azacitidine and Venetoclax Combination in the Treatment of Relapsed Acute Myeloid Leukemia: Experience of Two Clinical Cases". Oncology, Nuclear Medicine and Transplantology 2025 1 no. Suppl. 1 (2025): onmt_A21.
MLA
Suleimenova, A.S. et al. "Use of Azacitidine and Venetoclax Combination in the Treatment of Relapsed Acute Myeloid Leukemia: Experience of Two Clinical Cases". Oncology, Nuclear Medicine and Transplantology, vol. 1, no. Suppl. 1, 2025, onmt_A21.
REFERENCES
---
LICENSE

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.